Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Microb Pathog ; 141: 104011, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32004624

ABSTRACT

The antibacterial activities of apitoxin, a venom produced by Apis mellifera bee, and melittin, an antimicrobial peptide from apitoxin, were tested against planktonic and biofilm states of Staphylococcus aureus methicillin-resistant (MRSA), including clinical, and enterotoxin-producing isolates. Also, the synergism of apitoxin and melittin in combination with oxacillin were evaluated as well. The induced morphological changes on S. aureus cells of both products were detected by transmission electronic microscopy (TEM). The minimum inhibitory concentration (MIC) values were 7.2 µg/mL, and 6.7 µg/mL, for apitoxin and melittin, respectively. The minimum bactericidal concentration (MBC) values were 28.7 µg/mL, and 26 µg/mL for apitoxin and melittin, respectively. The time-kill curve assays of apitoxin or melittin with oxacillin exhibited bactericidal synergism against MRSA isolates. TEM images showed cell distortion, cell disintegration with leakage of cytoplasmic content and loss of cytoplasm content. However, apitoxin and melittin did not interfere with staphylococcal enterotoxin production or release. Thus, apitoxin and melittin are potential agents against MRSA that can serve as possible models for new antibacterial drugs.


Subject(s)
Bee Venoms/pharmacology , Melitten/pharmacology , Methicillin-Resistant Staphylococcus aureus/drug effects , Animals , Anti-Bacterial Agents/pharmacology , Bees/metabolism , Biofilms/drug effects , Drug Synergism , Humans , Microbial Sensitivity Tests , Oxacillin/pharmacology , Staphylococcal Infections/drug therapy
2.
J Pharm Pharmacol ; 70(12): 1688-1699, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30277563

ABSTRACT

OBJECTIVES: The human skin microbiota is mainly composed of bacteria belonging to the genera Staphylococcus, Cutibacterium, Micrococcus and Corynebacterium, but on the skin of the face and back, ca. 50% of the total microbiota is represented by the bacterium Cutibacterium acnes. The aim of this research was to evaluate the impact of C. martini EO and its major compound, geraniol, on C. acnes. METHODS: The minimum inhibitory concentration against C. acnes strains, phenotypic changes and responses of the proteome was determined. In addition, was assessed the effect of compounds in RNA-binding assay, on C. acnes-exposed keratinocytes and on the C. acnes type distribution on shoulder skin. KEY FINDINGS: The range of the MIC was 0.7 to 1.6 mg/ml for the three main C. acnes types. There were no cytotoxic effects of compounds in the absence or presence of C. acnes; after 7 days of exposure to C. martini EO, we could not detect a major shift of the C. acnes types on shoulder skin that was found to be dominated by C. acnes strains of types II and IA2. CONCLUSIONS: Our work gives novel insight into the skin microbiota-interacting properties of C. martini EO.


Subject(s)
Cymbopogon , Keratinocytes/drug effects , Oils, Volatile/pharmacology , Propionibacterium acnes/drug effects , Acyclic Monoterpenes , Dose-Response Relationship, Drug , Humans , Microbial Sensitivity Tests , Oils, Volatile/administration & dosage , Skin/drug effects , Terpenes/administration & dosage , Terpenes/pharmacology
3.
Nat Prod Res ; 32(12): 1441-1445, 2018 Jun.
Article in English | MEDLINE | ID: mdl-28641462

ABSTRACT

Propolis is a bee product with several biological properties. This study aimed at investigating a propolis-containing mouthwash, its organoleptic properties, microbial contamination and its antibacterial action in vitro. This mouthwash was assessed in vivo to control dental plaque in humans. The presence of microorganisms was analyzed and the minimum inhibitory concentration against Streptococcus mutans was determined. A comparative study was done in vivo using propolis, chlorhexidine, and propolis plus chlorhexidine in lower concentrations for 14 days. Dental plaque was analyzed by the Patient Hygiene Performance (PHP) index. The odontological product was yellow, cloudy, free of microbial contamination, and exerted an inhibitory action in vitro. Individuals who used a propolis-containing mouthwash for 14 consecutive days in combination or not to chlorhexidine showed a similar PHP index to chlorhexidine alone. The product exerted an antibacterial action in vitro and in vivo, exhibiting a positive action in the control of dental plaque.


Subject(s)
Anti-Bacterial Agents/pharmacology , Dental Plaque/prevention & control , Mouthwashes/pharmacology , Propolis/pharmacology , Adult , Chlorhexidine/pharmacology , Dental Plaque/microbiology , Female , Humans , Male , Microbial Sensitivity Tests , Streptococcus mutans/drug effects
4.
J Oleo Sci ; 64(1): 117-24, 2015.
Article in English | MEDLINE | ID: mdl-25492235

ABSTRACT

Consumption of chicken meat and its products, especially sausage, have increased in recent years. However, this product is susceptible to microbial contamination during manufacturing, which compromises its shelf life. The flavoring and preservative activities of essential oils (EO) have been recognized and the application of these antimicrobial agents as natural active compounds in food preservation has shown promise. The aim of this study was to evaluate the effect of Ocimum basilicum and Origanum vulgare EO on Listeria monocytogenes and Salmonella Enteritidis strains in artificially inoculated samples of fresh chicken sausage. First, the minimal inhibitory concentration (MIC) of EO in vitro was determined. The sausage was prepared and kept at ± 4°C; then, the inoculation of individual bacteria was carried out. EO were added at 0.3%, 1.0% and 1.5%v/w. After 0, 5, and 24 hours, the most probable number method (MPN) was performed. Transmission electron microscopy (TEM) was used to view the damage caused by these EO on bacterial morphology and/or structure. Only the 1.5% concentration was effective in reducing L. monocytogenes. 0.3% of O. vulgare EO was able to reduce the MPN/g of Salmonella Enteritidis (2 log) after 5 hours trials. O. basilicum EO showed no effect on Salmonella after 5 hours, but decreased by 2 log after 24 hours. O. vulgare EO at 1% gave a greater reduction of S. Enteritidis at 5 hours, increasing or maintaining this effect after 24 hours. The results confirmed the potential benefits of use EO in control of foodborne pathogens.


Subject(s)
Food Microbiology , Listeria monocytogenes/drug effects , Meat Products/microbiology , Ocimum basilicum/chemistry , Oils, Volatile/pharmacology , Origanum/chemistry , Salmonella enteritidis/drug effects , Animals , Anti-Bacterial Agents , Chickens , Dose-Response Relationship, Drug , Flavoring Agents , Food Contamination/prevention & control , Food Preservatives , Listeria monocytogenes/pathogenicity , Oils, Volatile/isolation & purification , Salmonella enteritidis/pathogenicity , Time
SELECTION OF CITATIONS
SEARCH DETAIL
...